← Back to Clinical Trials
Recruiting NCT06580158

NCT06580158 AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06580158
Status Recruiting
Phase
Sponsor Mayo Clinic
Condition Aortic Stenosis
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2024-11-08
Primary Completion 2027-03

Eligibility & Interventions

Sex All sexes
Min Age 60 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
AI-ECG DashboardPoint of care ultrasound (POCUS)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2024-11-08 with a primary completion date of 2027-03.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.

Eligibility Criteria

Inclusion Criteria: * ≥ 60 years of age must have a clinical scheduled ECG performed. Exclusion Criteria: * \< 59 years of age * Is not scheduled for a clinical ECG * Unable to provide consent.

Contact & Investigator

Central Contact

Brian Rudquist

✉ Rudquist.Brian@mayo.edu

📞 (507) 538-5146

Principal Investigator

Jae Oh, M.D.

PRINCIPAL INVESTIGATOR

Mayo Clinic

Frequently Asked Questions

Who can join the NCT06580158 clinical trial?

This trial is open to participants of all sexes, aged 60 Years or older, studying Aortic Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06580158 currently recruiting?

Yes, NCT06580158 is actively recruiting participants. Contact the research team at Rudquist.Brian@mayo.edu for enrollment information.

Where is the NCT06580158 trial being conducted?

This trial is being conducted at Rochester, United States.

Who is sponsoring the NCT06580158 clinical trial?

NCT06580158 is sponsored by Mayo Clinic. The principal investigator is Jae Oh, M.D. at Mayo Clinic. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology